BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1136 related articles for article (PubMed ID: 18469305)

  • 1. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of sirolimus but not cyclosporine ameliorates diabetic nephropathy in the rat.
    Wittmann S; Daniel C; Stief A; Vogelbacher R; Amann K; Hugo C
    Transplantation; 2009 May; 87(9):1290-9. PubMed ID: 19424027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta1, vascular endothelial growth factor, and bone morphogenic protein-7 expression in tacrolimus-induced nephrotoxicity in rats.
    Oğütmen B; Tuğlular S; Cakalağaoğlu F; Ozener C; Akoğlu E
    Transplant Proc; 2006 Mar; 38(2):487-9. PubMed ID: 16549155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene.
    Han DH; Piao SG; Song JH; Ghee JY; Hwang HS; Choi BS; Kim J; Yang CW
    Transplantation; 2010 Jul; 90(2):135-41. PubMed ID: 20562737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
    Yu X; Zhang B; Xing C; Sun B; Liu M; Zhang W; Gu M
    Transplant Proc; 2008 Dec; 40(10):3455-9. PubMed ID: 19100412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
    Nielsen FT; Ottosen P; Starklint H; Dieperink H
    Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine and rapamycin act in a synergistic and dose-dependent manner in a model of immunosuppressant-induced kidney damage.
    Brook NR; Waller JR; Bicknell GR; Nicholson ML
    Transplant Proc; 2005 Mar; 37(2):837-8. PubMed ID: 15848549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and renal tissue markers of nephropathy in rats under immunosuppressive therapy: cyclosporine versus sirolimus.
    Sereno J; Parada B; Rodrigues-Santos P; Lopes PC; Carvalho E; Vala H; Teixeira-Lemos E; Alves R; Figueiredo A; Mota A; Teixeira F; Reis F
    Transplant Proc; 2013 Apr; 45(3):1149-56. PubMed ID: 23622648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion to low-dose tacrolimus or rapamycin 3 months after kidney transplantation: a prospective, protocol biopsy-guided study.
    Pankewycz O; Leca N; Kohli R; Weber-Shrikant E; Said M; Alnimri M; Feng L; Patel S; Laftavi MR
    Transplant Proc; 2011 Mar; 43(2):519-23. PubMed ID: 21440749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
    Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between cyclosporine-induced nephrotoxicity in reduced nephron mass and expression of kidney injury molecule-1 and aquaporin-2 gene.
    Hong ME; Hong JC; Stepkowski S; Kahan BD
    Transplant Proc; 2005 Dec; 37(10):4254-8. PubMed ID: 16387092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus and cyclosporine A alter barrier function in renal proximal tubular cells through stimulation of ERK1/2 signaling and claudin-1 expression.
    Martin-Martin N; Ryan G; McMorrow T; Ryan MP
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F672-82. PubMed ID: 19955189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney.
    Sun BK; Li C; Lim SW; Jung JY; Lee SH; Kim IS; Kim YS; Kim J; Bang BK; Yang CW
    J Lab Clin Med; 2004 Mar; 143(3):175-83. PubMed ID: 15007308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin.
    Ryffel B; Weber E; Mihatsch MJ
    Exp Nephrol; 1994; 2(6):324-33. PubMed ID: 7532090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
    Oberbauer R; Kreis H; Johnson RW; Mota A; Claesson K; Ruiz JC; Wilczek H; Jamieson N; Henriques AC; Paczek L; Chapman J; Burke JT;
    Transplantation; 2003 Jul; 76(2):364-70. PubMed ID: 12883194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.
    Shihab FS; Bennett WM; Yi H; Choi SO; Andoh TF
    Kidney Int; 2004 Apr; 65(4):1262-71. PubMed ID: 15086465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction.
    Piao SG; Bae SK; Lim SW; Song JH; Chung BH; Choi BS; Yang CW
    Transplantation; 2012 Feb; 93(4):383-9. PubMed ID: 22267156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.